<DOC>
	<DOCNO>NCT01203592</DOCNO>
	<brief_summary>The study test notion patient suffer certain type congenital myasthenic syndrome benefit use Albuterol dose use clinical practice .</brief_summary>
	<brief_title>Efficacy Albuterol Treatment Congenital Myasthenic Syndromes</brief_title>
	<detailed_description>The aim proposal evaluate effect albuterol , adrenergic agonist , treatment congenital myasthenic syndrome ( CMS ) . Over past 2 decade I find CMS patient refractory worsen cholinergic agonist , namely suffer defect acetylcholinesterase ( AChE ) Dok-7 , respond ephedrine , medication use half-a-century treatment autoimmune myasthenia gravis . After ephedrine become unavailable , I treat type patient albuterol dose range 4 mg daily twice daily adult ; dose child 6 12 year 2 mg two three time daily ; dose child 2 6 year 0.1 mg/kg/day ( maximum 2 mg ) three time daily . Evaluation effect medication base Table show . Name : Mayo Clinic : Date report : ( dd/mm/yyyy ) : Before take Albuterol ER On Albuterol ( date report ) - Current daily dose albuterol : Dates start ( d/m/year ) Daily dose Distance foot walk without stop rest Number step climb without stop rest Difficult sit lie back* Difficult rise sitting* Difficult speak swallow* Shortness breath exertion* Shortness breath night* Weakness arm hand muscle * Weakness leg foot muscles* *Rate mild , moderate , severe Describe additional change condition arm elevation time , number deep knee bend stop , activity daily live relevant effect treatment . Also indicate unwanted side effect medication . Continue side separate page necessary . Return questionnaire Dr. Andrew Engel ( email : schaefer.cleo @ mayo.edu ) , treatment albuterol 1 month monthly thereafter , mail Dr. Andrew Engel , Department Neurology , Mayo Clinic , Rochester , MN 55905 .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Lambert-Eaton Myasthenic Syndrome</mesh_term>
	<mesh_term>Myasthenic Syndromes , Congenital</mesh_term>
	<mesh_term>Albuterol</mesh_term>
	<criteria>Diagnosis congenital myasthenic syndrome substantiate typical clinical history , seronegativity AChR MuSK , evidence decremental EMG response . Uncontrolled hypertension , arrhythmia , significant cardiac disease .</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2015</verification_date>
	<keyword>Congenital myasthenic syndrome</keyword>
	<keyword>Albuterol</keyword>
	<keyword>Neuromuscular transmission</keyword>
</DOC>